Salve medicina - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 30,675 | 62,932 | 96,343 | 132,401 | 221,538 | 223,172 | 315,568 | 410,978 |
| Profit before tax | 12,899 | 15,572 | 40,767 | 25,238 | 82,518 | 88,316 | 98,179 | 100,163 |
| Net profit | 12,423 | 14,802 | 38,718 | 23,923 | 78,377 | 74,961 | 83,050 | 83,692 |
| Equity | 12,673 | 17,303 | 55,608 | 79,531 | 121,437 | 196,398 | 261,801 | 345,485 |
| Liabilities | 1,166 | 3,836 | 4,265 | 10,084 | 12,792 | 24,648 | 67,267 | 24,814 |
| Non-current assets | 633 | 10,724 | 8,826 | 27,117 | 22,661 | 166,577 | 264,161 | 247,850 |
| Current assets | 13,188 | 10,339 | 50,870 | 62,155 | 110,870 | 54,152 | 64,611 | 122,217 |
| Total assets | 13,821 | 21,063 | 59,696 | 89,272 | 133,531 | 220,729 | 328,772 | 370,067 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 19,699 | 42,327 | 65,064 |
| Social insurance contributions | - | - | - | - | - | 12,883 | 27,798 | 40,903 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | +105.2% | +53.1% | +37.4% | +67.3% | +0.7% | +41.4% | +30.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 89.9% | 70.3% | 64.9% | 26.8% | 58.7% | 34.0% | 25.3% | 22.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 98.0% | 85.5% | 69.6% | 30.1% | 64.5% | 38.2% | 31.7% | 24.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 40.5% | 23.5% | 40.2% | 18.1% | 35.4% | 33.6% | 26.3% | 20.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 42.1% | 24.7% | 42.3% | 19.1% | 37.2% | 39.6% | 31.1% | 24.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 30,675 | 37,758 | 17,517 | 17,852 | 31,276 | 34,780 | 63,114 | 72,525 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Salve medicina - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2021-10-18 | 2021-10-19 | 0.01 |
| 2021-09-16 | 2021-10-13 | 0.01 |
Salve medicina - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Salve medicina, UAB (code 304481993) is a Private Limited Liability Company engaged in medical specialists activities. In the latest financial year, 2025, the company generated revenue of €411.0K and net profit of €83.7K, with a profit margin of 20.4%. Revenue increased by 30.2% year on year and by 84.2% over two years, showing strong top-line expansion from €223.2K in 2023 to €315.6K in 2024 and then to €411.0K in 2025. Net profit remained broadly stable across the period, rising from €75.0K in 2023 to €83.0K in 2024 and €83.7K in 2025, while the margin narrowed as revenue grew faster than earnings. At the end of 2025, total assets stood at €370.1K, equity at €345.5K, and liabilities at €24.8K, indicating a very strong equity position. Key ratios for 2025 were ROE of 24.2%, ROA of 22.6%, debt-to-equity of 0.07, and asset turnover of 1.11x. Revenue per employee was €82.2K, with profit per employee of €16.7K.